Product Images Nabumetone

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Nabumetone NDC 0440-5844 by Liberty Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Structure - nabumetone tablet 1

Structure - nabumetone tablet 1

6MNA - nabumetone tablet 2

6MNA - nabumetone tablet 2

Figure - nabumetone tablet 3

Figure - nabumetone tablet 3

This is a graph that shows the plasma concentrations of Nabumetone Active Metabolite (MNA) at steady state, following once-daily dosing of nabumetone of 1000 mg and 2000 mg. The graph displays the concentration in mega/mL over time in hours. The group of 1000 mg has 31 subjects while the 2000 mg has 12 subjects. There are error bars SD (Standard Deviation) for both groups to illustrate the variability of the data.*

IMAGE - nabumetone tablet 4

IMAGE - nabumetone tablet 4

IMAGE - nabumetone tablet 5

IMAGE - nabumetone tablet 5

This is a prescription drug sold by Liberty Pharmaceuticals Inc. under the brand name RXONLY. The medicine contains NABUMETONE, USP 750MG and is sold in a package of 90 tablets. The tablets are white, oval-shaped, imprinted with "257" on one side and "APO" on the other. The drug is used to treat inflammation and pain caused by arthritis. It is intended for use in government medical facilities only and commercial use is strictly prohibited. The manufacturer is Exelan Pharmaceuticals Inc based in Lawrenceville, GA with an expiry date of BL1ASOPN.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.